Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer–myositis connection

Abstract excerpt

Phenotype-specific autoantibodies are clinically important toolsAcross the breadth of autoimmune rheumatic diseases, there is a striking association of specific autoantibodies with distinct clinical phenotypes, making them excellent tools for subsetting patients, predicting disease course and outcomes.Within the myositis spectrum, there are numerous examples of this.Over two decades ago, it was noted that...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Eosinophilic Disorders and Syndromes
• Share to Inflammatory Myopathies and Dermatomyositis
• Share to Skin Diseases and Diabetes